1. Home
  2. CELU vs AGAE Comparison

CELU vs AGAE Comparison

Compare CELU & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • AGAE
  • Stock Information
  • Founded
  • CELU 2016
  • AGAE 2017
  • Country
  • CELU United States
  • AGAE United States
  • Employees
  • CELU N/A
  • AGAE N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • AGAE Cable & Other Pay Television Services
  • Sector
  • CELU Health Care
  • AGAE Telecommunications
  • Exchange
  • CELU Nasdaq
  • AGAE Nasdaq
  • Market Cap
  • CELU 42.2M
  • AGAE 38.8M
  • IPO Year
  • CELU N/A
  • AGAE N/A
  • Fundamental
  • Price
  • CELU $1.61
  • AGAE $1.01
  • Analyst Decision
  • CELU
  • AGAE
  • Analyst Count
  • CELU 0
  • AGAE 0
  • Target Price
  • CELU N/A
  • AGAE N/A
  • AVG Volume (30 Days)
  • CELU 54.8K
  • AGAE 18.1K
  • Earning Date
  • CELU 12-06-2024
  • AGAE 05-19-2025
  • Dividend Yield
  • CELU N/A
  • AGAE N/A
  • EPS Growth
  • CELU N/A
  • AGAE N/A
  • EPS
  • CELU N/A
  • AGAE N/A
  • Revenue
  • CELU $48,200,000.00
  • AGAE $9,256,023.00
  • Revenue This Year
  • CELU N/A
  • AGAE N/A
  • Revenue Next Year
  • CELU $233.89
  • AGAE N/A
  • P/E Ratio
  • CELU N/A
  • AGAE N/A
  • Revenue Growth
  • CELU 225.94
  • AGAE 36.15
  • 52 Week Low
  • CELU $1.00
  • AGAE $0.61
  • 52 Week High
  • CELU $5.22
  • AGAE $1.57
  • Technical
  • Relative Strength Index (RSI)
  • CELU 49.49
  • AGAE 51.15
  • Support Level
  • CELU $1.47
  • AGAE $0.96
  • Resistance Level
  • CELU $1.77
  • AGAE $1.02
  • Average True Range (ATR)
  • CELU 0.16
  • AGAE 0.07
  • MACD
  • CELU 0.01
  • AGAE 0.01
  • Stochastic Oscillator
  • CELU 63.04
  • AGAE 70.13

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

Share on Social Networks: